Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 188 | 153 | 1,024 | 2 | -21 |
| Cost of Goods | 320 | 242 | N/A | N/A | 0 |
| Gross Profit | -132 | -90 | 728 | 2 | -21 |
| Operating Expenses | 3,156 | 3,151 | 2,495 | 3,674 | 3,807 |
| Operating Income | -2,968 | -2,999 | -1,471 | -3,672 | -3,828 |
| Other Income | -15 | -1 | 30 | 109 | -189 |
| Pre-tax Income | -2,983 | -3,000 | -1,442 | -3,563 | -4,017 |
| Net Income Continuous | -2,983 | -3,000 | -1,442 | -3,563 | -4,017 |
| Net Income | $-2,983 | $-3,000 | $-1,442 | $-3,563 | $-4,017 |
| EPS Basic Total Ops | -0.20 | -0.21 | 0.03 | -0.28 | -0.45 |
| EPS Basic Continuous Ops | -0.20 | -0.21 | 0.03 | -0.28 | -0.45 |
| EPS Diluted Total Ops | -0.20 | -0.21 | 0.03 | -0.28 | -0.45 |
| EPS Diluted Continuous Ops | -0.20 | -0.21 | 0.03 | -0.28 | -0.45 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.20 | -0.02 | -0.28 | -0.45 |
| EBITDA(a) | $-2,396 | $-2,444 | $-1,073 | $-3,066 | $-3,374 |